MoneyWorks4Me

Dr. Lal PathLabs informs about analyst meet

29 Aug 2022 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal PathLabs has informed that it enclosed the details of proposed schedule of Analyst/ Institutional Investor meeting(s). Dates of the aforesaid meeting/call are subject to change due to exigencies on the part of Investor/ Company. No Unpublished Price Sensitive Information will be shared during the meeting.

The above information is a part of company’s filings submitted to BSE.

Peers